2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, GS; Blum, CA; Dashwood, RH; Fong, AT; Horio, DT; Orner, GA; Stoner, GD; Xu, M | 1 |
1 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and cyclin d1
Article | Year |
---|---|
beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; beta Catenin; Carcinogens; Chlorophyllides; Colonic Neoplasms; Cyclin D1; Cytoskeletal Proteins; DNA Mutational Analysis; Hypoxanthine Phosphoribosyltransferase; Indoles; Male; Mutation; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Quinolines; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators | 2001 |